CID 3045380

Lorpiprazole

Structural Information

Molecular Formula
C21H26F3N5
SMILES
C1C[C@@H]2CN3C(=NN=C3[C@@H]2C1)CCN4CCN(CC4)C5=CC=CC(=C5)C(F)(F)F
InChI
InChI=1S/C21H26F3N5/c22-21(23,24)16-4-2-5-17(13-16)28-11-9-27(10-12-28)8-7-19-25-26-20-18-6-1-3-15(18)14-29(19)20/h2,4-5,13,15,18H,1,3,6-12,14H2/t15-,18-/m1/s1
InChIKey
BNRMWKUVWLKDQJ-CRAIPNDOSA-N
Compound name
(1R,8S)-5-[2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-3,4,6-triazatricyclo[6.3.0.02,6]undeca-2,4-diene
Related CIDs

2D Structure

compound 2d structure
4
Annotation Hits

2
References

146
Patents

405.21402 Da
Monoisotopic Mass

3.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 406.22130 198.0
[M+Na]+ 428.20324 204.1
[M-H]- 404.20674 199.2
[M+NH4]+ 423.24784 208.9
[M+K]+ 444.17718 197.2
[M+H-H2O]+ 388.21128 184.6
[M+HCOO]- 450.21222 204.8
[M+CH3COO]- 464.22787 204.2
[M+Na-2H]- 426.18869 191.3
[M]+ 405.21347 190.8
[M]- 405.21457 190.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.